SOPHiA GENETICS (SOPH) has released an update.
Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
SOPHiA GENETICS SA has reported its unaudited interim condensed consolidated financial results, indicating a gross profit increase for the three and six months ended June 30, 2024, compared to the same periods in 2023. However, the company is also facing significant research and development as well as general and administrative costs, impacting their overall financial position.
For further insights into SOPH stock, check out TipRanks’ Stock Analysis page.
